Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: Systematic review and meta-analysis

European Journal of Endocrinology

Volumn 173, Issue 1, 2015, Pages 101-109

  Donga, Esther ^a   Dekkers, Olaf M ^a   Corssmit, Eleonora P M ^a   Romijn, Johannes A ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE;

ADULT; CLINICAL FEATURE; FATTY ACID BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE DISPOSAL RATE; GLUCOSE INFUSION RATE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOLYSIS; META ANALYSIS; METABOLIC CLEARANCE RATE; METABOLIC PARAMETERS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYMPTOM ASSESSMENT; SYSTEMATIC REVIEW; BLOOD; DIABETES MELLITUS, TYPE 1; FEMALE; MALE; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; YOUNG ADULT;

ADULT; DIABETES MELLITUS, TYPE 1; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; LIPOLYSIS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84935121741     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0911     Document Type: Review

References (54)

1. DeFronzo RA, Simonson D & Ferrannini E. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1982 23 313-319. (doi:10.1007/BF00253736)
2. Yki-Jarvinen H & Koivisto VA. Natural course of insulin resistance in type I diabetes. New England Journal of Medicine 1986 315 224-230. (doi:10.1056/NEJM198607243150404)
3. Kacerovsky M, Brehm A, Chmelik M, Schmid AI, Szendroedi J, Kacerovsky-Bielesz G, Nowotny P, Lettner A, Wolzt M, Jones JG et al. Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes. Journal of Internal Medicine 2011 269 189-199. (doi:10.1111/j.1365-2796.2010.02298.x)
4. Simonson DC, Tamborlane WV, Sherwin RS, Smith JD & DeFronzo RA. Improved insulin sensitivity in patients with type I diabetes mellitus after CSII. Diabetes 1985 34 (Suppl 3) 80-86. (doi:10.2337/diab.34.3.S80)
5. Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY, Smithline KL, Ellis D & Becker DJ. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2003 26 1374-1379. (doi:10.2337/diacare.26.5.1374)
6. Chaturvedi N, Sjoelie AK, Porta M, Aldington SJ, Fuller JH, Songini M, Kohner EM & EURODIAB Prospective Complications Study. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care, 2001 284-289. (doi:10.2337/diacare.24.2.284)
7. Kilpatrick ES, Rigby AS & Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes"in the Diabetes Control and Complications Trial. Diabetes Care 2007 30 707-712. (doi:10.2337/dc06-1982)
8. DeFronzo RA, Tobin JD & Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology 1979 237 E214-E223.
9. Rosenblatt J & Wolfe RR. Calculation of substrate flux using stable isotopes. American Journal of Physiology 1988 254 E526-E531.
10. Del Prato S, Matsuda M, Simonson DC, Groop LC, Sheehan P, Leonetti F, Bonadonna RC & DeFronzo RA. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance. Diabetologia 1997 40 687-697. (doi:10.1007/s001250050735)
11. Fasching P, Ratheiser K, Damjancic P, Schneider B, Nowotny P, Vierhapper H & Waldhausl W. Both acute and chronic near-normoglycaemia are required to improve insulin resistance in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993 36 346-351. (doi:10.1007/BF00400239)
12. Maahs DM, Hokanson JE, Wang H, Kinney GL, Snell-Bergeon JK, East A, Bergman BC, Schauer IE, Rewers M & Eckel RH. Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance. Diabetes 2010 59 1771-1779. (doi:10.2337/db09-1626)
13. Pereira RI, Snell-Bergeon JK, Erickson C, Schauer IE, Bergman BC, Rewers M & Maahs DM. Adiponectin dysregulation and insulin resistance in type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 2012 97 E642-E647. (doi:10.1210/jc.2011-2542)
14. Yki-Jarvinen H, DeFronzo RA & Koivisto VA. Normalization of insulin sensitivity in type I diabetic subjects by physical training during insulin pump therapy. Diabetes Care 1984 7 520-527. (doi:10.2337/diacare.7.6.520)
15. Yki-Jarvinen H & Koivisto VA. Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 1984 58 659-666. (doi:10.1210/jcem-58-4-659)
16. Nijs HG, Radder JK, Frolich M & Krans HM. The course and determinants of insulin action in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1989 32 20-27. (doi:10.1007/BF00265399)
17. Baron AD, Laakso M, Brechtel G & Edelman SV. Mechanism of insulin resistance in insulin-dependent diabetes-mellitus - a major role for reduced skeletal-muscle blood-flow. Journal of Clinical Endocrinology and Metabolism 1991 73 637-643. (doi:10.1210/jcem-73-3-637)
18. Bergman BC, Howard D, Schauer IE, Maahs DM, Snell-Bergeon JK, Eckel RH, Perreault L & Rewers M. Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 2012 97 1663-1672. (doi:10.1210/jc.2011-3172)
19. Bravard A, Lefai E, Meugnier E, Pesenti S, Disse E, Vouillarmet J, Peretti N, Rabasa-Lhoret R, Laville M, Vidal H et al. FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction. Diabetes 2011 60 258-268. (doi:10.2337/db10-0281)
20. nd Scientific Sessions of the American Diabetes Association Philadelphia: June 2012.
21. Del Prato S, Nosadini R, Tiengo A, Tessari P, Avogaro A, Trevisan R, Valerio A, Muggeo M, Cobelli C & Toffolo G. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. Journal of Clinical Endocrinology and Metabolism 1983 57 904-910. (doi:10.1210/jcem-57-5-904)
22. Donga E, van DM, Hoogma RP, Corssmit EP & Romijn JA. Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long-term continuous subcutaneous insulin infusion therapy. Diabetes/Metabolism Research and Reviews 2013 29 33-38. (doi:10.1002/dmrr.2343)
23. Ebeling P, Essen-Gustavsson B, Tuominen JA & Koivisto VA. Intramuscular triglyceride content is increased in IDDM. Diabetologia 1998 41 111-115. (doi:10.1007/s001250050875)
24. Ekstrand AV, Groop PH & Gronhagen-Riska C. Insulin resistance precedes microalbuminuria in patients with insulin-dependent diabetes mellitus. Nephrology, Dialysis, Transplantation 1998 13 3079-3083. (doi:10.1093/ndt/13.12.3079)
25. Greenfield JR, Samaras K & Chisholm DJ. Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2002 87 1036-1040. (doi:10.1210/jcem.87.3.8324)
26. Hother-Nielsen O, Schmitz O, Bak J & Beck-Nielsen H. Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes. Diabetologia 1987 30 834-840.
27. Hsu WC, Okeke E, Cheung S, Keenan H, Tsui T, Cheng K & King GL. A cross-sectional characterization of insulin resistance by phenotype and insulin clamp in East Asian Americans with type 1 and type 2 diabetes. PLoS ONE 2011 6 e28311. (doi:10.1371/journal.pone.0028311)
28. Keller U, Muller R & Berger W. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects. Hormone and Metabolic Research 1986 18 599-603. (doi:10.1055/s-2007-1012384)
29. Kerner W, Navascues I, von ST, Fussganger R, Arias P & Pfeiffer EF. Characterization of insulin resistance in type I diabetes. Klinische Wochenschrift 1985 63 545-553. (doi:10.1007/BF01733199)
30. Kruszynska YT, Petranyi G, Home PD, Taylor R & Alberti KG. Muscle enzyme activity and insulin sensitivity in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1986 29 699-705. (doi:10.1007/BF00870279)
31. Lager I, Lonnroth P, von SH & Smith U. Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion. BMJ 1983 287 1661-1664. (doi:10.1136/bmj.287.6406.1661)
32. Makimattila S, Virkamaki A, Groop PH, Cockcroft J, Utriainen T, Fagerudd J & Yki-Jarvinen H. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 1996a 94 1276-1282. (doi:10.1161/01.CIR.94.6.1276)
33. Makimattila S, Virkamaki A, Malmstrom R, Utriainen T & Yki-Jarvinen H. Insulin resistance in type I diabetes mellitus: a major role for reduced glucose extraction. Journal of Clinical Endocrinology and Metabolism 1996b 81 707-712.
34. Nijs HG, Radder JK, Poorthuis BJ & Krans HM. Glucose disposal and intermediary metabolism during one year of continuous subcutaneous insulin infusion (CSII). Diabetes Research and Clinical Practice 1991 12 1-9. (doi:10.1016/0168-8227(91)90124-V)
35. Nuutila P, Knuuti J, Ruotsalainen U, Koivisto VA, Eronen E, Teras M, Bergman J, Haaparanta M, Voipio-Pulkki LM & Viikari J. Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes. American Journal of Physiology 1993 264 E756-E762.
36. Pernet A, Trimble ER, Kuntschen F, Damoiseaux P, Assal JP, Hahn C &Renold AE. Insulin resistance in type 1 (insulin-dependent) diabetes: dependence on plasma insulin concentration. Diabetologia 1984 26 255-260. (doi:10.1007/BF00283646)
37. Perseghin G, Lattuada G, Danna M, Sereni LP, Maffi P, De CF, Battezzati A, Secchi A, Del MA & Luzi L. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. American Journal of Physiology. Endocrinology and Metabolism 2003 285 E1174-E1181. (doi:10.1152/ajpendo.00279.2003)
38. Perseghin G, Lattuada G, De CF, Esposito A, Costantino F, Canu T, Scifo P, De TF, Maffi P, Secchi A et al. Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes. Diabetologia 2005 48 2615-2621. (doi:10.1007/s00125-005-0014-5)
39. Rosenfalck AM, Almdal T, Viggers L, Madsbad S & Hilsted J. A low-fat diet improves peripheral insulin sensitivity in patients with Type 1 diabetes. Diabetic Medicine 2006 23 384-392. (doi:10.1111/j.1464-5491.2005.01810.x)
40. Schauer IE, Snell-Bergeon JK, Bergman BC, Maahs DM, Kretowski A, Eckel RH & Rewers M. Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: the CACTI study. Diabetes 2011 60 306-314. (doi:10.2337/db10-0328)
41. Shay CM, Secrest AM, Miller RG, Strotmeyer ES, Goodpaster BH, Kelsey SF & Orchard TJ. Femoral-gluteal adiposity is not associated with insulin sensitivity in type 1 diabetes. Diabetic Medicine 2012 29 1407-1411. (doi:10.1111/j.1464-5491.2012.03728.x)
42. Tessari P, Nosadini R, Trevisan R, De Kreutzenberg SV, Inchiostro S, Duner E, Biolo G, Marescotti MC, Tiengo A & Crepaldi G. Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism. Journal of Clinical Investigation 1986 77 1797-1804. (doi:10.1172/JCI112504)
43. Trevisan R, Nosadini R, Avogaro A, Lippe G, Duner E, Fioretto P, Deana R, Tessari P, Tiengo A & Velussi M. Type I diabetes is characterized by insulin resistance not only with regard to glucose, but also to lipid and amino acid metabolism. Journal of Clinical Endocrinology and Metabolism 1986 62 1155-1162. (doi:10.1210/jcem-62-6-1155)
44. Yki-Jarvinen H, Taskinen MR, Kiviluoto T, Hilden H, Helve E, Koivisto VA & Nikkila EA. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro. Journal of Clinical Endocrinology and Metabolism 1984b 59 1183-1192. (doi:10.1210/jcem-59-6-1183)
45. Yki-Jarvinen H, Helve E & Koivisto VA. Relationship between oral glucose tolerance and insulin sensitivity in healthy man and type 1 diabetic patients. Acta Endocrinologica 1986 112 355-360.
46. Sandoval DA, Guy DL, Richardson MA, Ertl AC & Davis SN. Acute, same-day effects of antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes mellitus. American Journal of Physiology. Endocrinology and Metabolism 2006 290 E1331-E1338. (doi:10.1152/ajpendo.00283.2005)
47. Yki-Jarvinen H, Helve E & Koivisto VA. Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes 1987 36 892-896. (doi:10.2337/diab.36.8.892)
48. Jacob S, Rett K, Wicklmayr M, Agrawal B, Augustin HJ & Dietze GJ. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study. Journal of Hypertension 1996 14 489-494. (doi:10.1097/00004872-199604000-00012)
49. Chimen M, Kennedy A, Nirantharakumar K, Pang TT, Andrews R &Narendran P. What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review Diabetologia 2012 55 542-551. (doi:10.1007/s00125-011-2403-2)
50. Landt KW, Campaigne BN, James FW & Sperling MA. Effects of exercise training on insulin sensitivity in adolescents with type I diabetes. Diabetes Care 1985 8 461-465. (doi:10.2337/diacare.8.5.461)
51. Donga E, van DM, van Dijk JG, Biermasz NR, Lammers GJ, van KK, Hoogma RP, Corssmit EP & Romijn JA. Partial sleep restriction decreases insulin sensitivity in type 1 diabetes. Diabetes Care 2010 33 1573-1577. (doi:10.2337/dc09-2317)
52. Teupe B & Bergis K. Epidemiological evidence for "double diabetes". Lancet 1991 337 361-362. (doi:10.1016/0140-6736(91)90988-2)
53. Bratusch-Marrain PR, Komjati M & Waldhäusl WK. Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans. Diabetes 1986 35 922-926. (doi:10.2337/diab.35.8.922)
54. Catalano KJ, Maddux BA, Szary J, Youngren JF, Goldfine ID &Schaufele F. Insulin resistance induced by hyperinsulinemia coincides with a persistent alteration at the insulin receptor tyrosine kinase domain. PLoS ONE 2014 9 e108693. (doi:10.1371/journal.pone.0108693)